approaches to aid in the diagnosis of alzheimer's disease by measurement of amyloid - betapeptid (x - amp; 41) and tau

• 1. 肽、抗肽抗体以及用它们来诊断和治疗淀粉样蛋白相关疾病的方法 [P] . 中国专利： CN101415724B . 2015.12.02
• 2. 肽、抗肽抗体以及用它们来诊断和治疗淀粉样蛋白相关疾病的方法 [P] . 中国专利： CN101415724A . 2009-04-22
• 3. METHOD FOR AIDING IN DIAGNOSIS OF ALZHEIMER'S DISEASE BY MEASURING AMYLOID-BETA PEPTIDE (X-amp;ge;41) AND TAU [P] . 日本专利： JP2004077499A . 2004-03-11

  机译： 通过测定淀粉样蛋白肽（X-＆ge; 41）和TAU来诊断老年痴呆症的方法

• 4. Methods for aiding in the diagnosis of alzheimer's disease by measuring amyloid-β peptide (X-41) and tau [P] . 美国专利： US7700309B2 . 2010-04-20

  机译： 通过测量β淀粉样蛋白（X-> 41）和tau蛋白来帮助诊断阿尔茨海默氏病的方法

• 5. Methods for aiding in the diagnosis of Alzheimer's disease by measuring amyloid-β peptide (x-≧41) and tau [P] . 美国专利： US7811769B2 . 2010-10-12

  机译： 通过测量淀粉样β肽（x-≧41）和tau来帮助诊断阿尔茨海默氏病的方法

• 1. Amyloid-beta peptide and tau protein crosstalk in Alzheimer 's disease [J] . Alejandro R.Roda, Gabriel Serra-Mir, Laia Montoliu-Gaya, 中国神经再生研究（英文版） . 2022,第008期
• 2. Buyuan Congnao decoction decreases hippocampal beta-amyloid expression in a rat model of Alzheimer's disease [J] . Min Chen, Jing Wang, Cairong Ming 中国神经再生研究（英文版） . 2012,第009期
• 3. 3D profiling of amyloid plaque-associated microglia and neuronal damage on confocal uorescence images to aid drug discovery in Alzheimer's Disease [C] . Ilknur Icke, Alice Zhang, Sonal Singh, SPIE Medical Imaging Conference . 2019
• 4. Targeted siRNA-mediated down-regulation of the expression of amyloid precursor and tau proteins implicated in Alzheimer's disease in neuroblastoma cell lines. [D] . Patel, Krishna. 2016
• 5. Cerebrospinal fluid phospho-tau T217 outperforms T181 as a biomarker for the differential diagnosis of Alzheimer’s disease and PET amyloid-positive patient identification [O] . Nicolas R. Barthélemy, Randall J. Bateman, Christophe Hirtz, 2020
• 6. Amyloid-beta(1-42), Total Tau, and Phosphorylated Tau as Cerebrospinal Fluid Biomarkers for the Diagnosis of Alzheimer Disease [O] . Mulder, C., Verwey, N.A., van der Flier, W.M., 2010

• 1. Amyloid beta peptides, tau protein acetylation and therapeutic strategies for treating Alzheimer’s disease: a review [J] . Sanjib Guha ,Rajalakshmi Subramaniyam . 生命研究 . 2021,第001期
• 2. CSF tau and amyloid βsub42/sublevels in Alzheimer’s disease—A meta-analysis [J] . Rachna Agarwal ,Neelam Chhillar ,Vijay Nath Mishra . 阿尔茨海默氏病研究进展（英文） . 2012,第3期
• 3. iRatanasampil/i(Tibetan Medicine, RNSP) Reduces iβ/i-Amyloid Protein (Aβ) and Pro-Inflammatory Factor Levels and Improves Cognitive Functions in Mild-to-Moderate Alzheimer’s Disease (AD) Patients Living at High Altitude [J] . Aiqin Zhu ,Aiqi Xi ,Guofeng Li . 行为与脑科学期刊（英文） . 2012,第1期
• 4. 雷公藤红素对β淀粉样蛋白诱导SH-SY5Y细胞Tau蛋白异常磷酸化影响的研究 [C] . 曹帆帆 ,徐莉敏 ,王莹 . 第六届全国雷公藤学术会议 . 2017
• 5. 脑脊液β淀粉样蛋白及Tau蛋白对阿尔茨海默病源性轻度认知功能损害患者诊断的临床价值研究 [A] . 陈英道 . 2014